Annoroad, a Annoroad gene-sequencing firm, has raised $105m in a series C funding round led by Shenzhen GTJA Investment Group and Shenzhen GTJA Investment Group . SoftBank China Venture Capital also invested in the round. China -based Annoroad is recognised for its fertility and tumour test products, and is one of the largest genomics companies in Beijing . That resulted in NextSeq550AR, a sequencing platform the company said the windfall will partly go toward developing its overseas business efforts, though it didn’t elaborate. The funds will be used to develop the company's overseas business connections, improve its R&D efforts and hire further staff. Some funding will be used for its Ping An Ventures subsidiary, which offers a cloud-based platform for the storage of bioinformatics and research.
Annoroad, a Annoroad gene-sequencing firm, has raised $105m in a series C funding round led by Shenzhen GTJA Investment Group and Shenzhen GTJA Investment Group . SoftBank China Venture Capital also invested in the round. China -based Annoroad is recognised for its fertility and tumour test products, and is one of the largest genomics companies in Beijing . The funds will be used to develop the company's overseas business connections, improve its R&D efforts and hire further staff. Some funding will be used for its Ping An Ventures subsidiary, which offers a cloud-based platform for the storage of bioinformatics and research.